- GW Home
- About GW
- University Life
- News & Events
- Faculty And Staff
3D printed vascularized tissue scaffold with extracellular matrix triggered growth factor releaseTechnology #016-006-zhang
Questions about this technology? Ask a Technology Manager
- Image Gallery
- Haitao Cui
- Wei Zhu
- Benjamin Holmes
- Lijie Grace Zhang External Link (home.gwu.edu)
- Managed By
- Brian Coblitz Sr. Licensing Associate firstname.lastname@example.org (202) 994-4345
- Patent Protection
SMART RELEASE SYSTEM FOR GROWTH FACTOR DELIVERY AND COMBINED BONE AND VASCULAR GROWTHUS Patent Pending 2018-0015207
- Biologically Inspired Smart Release System Based on 3D Bioprinted Perfused Scaffold for Vascularized Tissue Regeneration Advanced Science, Apr. 15, 2016,
“Vas-Scaf” is a 3D bio-printed vascularized bone scaffold perfused with osteogenic and angiogenic growth factors. Artificial bone grafts lacking vascularization fail due to poor integration of new tissues with the host and death of interior bone tissues. Bone and blood vessel tissues require different support structures and different biochemical stimuli to support tissue growth and differentiation. “Vas-Scaf” regulates osteogenesis and angiogenesis through growth factors BMP-2 and VEGF, respectively, with both immobilized in their specific regions of the scaffold.
“Vas-Scaf” fabrication starts with a nano-coating to enable the delivery of BMP-2 and VEGF at specified places and times. This nano-coating selectively releases the two growth factors through when in the presence of extracellular matrix enzymes, thereby delivering stimuli at the appropriate time.
The integration of a strong 3D-printed scaffold with features designed for bone and vascular growth with immobilization of tissue-specific biochemically-released growth factors in each feature can create an ideal bone graft.
Bone defect reconstruction
Large scale bone defect reconstruction through vascularization
Lowered risk of necrosis
Fine spatial control of multiple growth factor placement